https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 The Hep573 Study: a randomised, double-blind, placebo-controlled clinical trial of silymarin alone, and silymarin combined with antioxidants in chronic hepatitis C https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13378 Wed 11 Apr 2018 12:47:29 AEST ]]> Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: analysis from the PREDICT and CHARIOT studies https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20861 Sat 24 Mar 2018 08:02:53 AEDT ]]>